Suppr超能文献

艾滋病毒/艾滋病患者与合并精神疾病者的慢性病负担。

Burden of Chronic Conditions Among Persons with HIV/AIDS and Psychiatric Comorbidity.

机构信息

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States.

Corporal Michael J. Crescenz VAMC, Philadelphia, PA, 19104, United States.

出版信息

Curr HIV Res. 2021;19(6):504-513. doi: 10.2174/1570162X19666210805092258.

Abstract

BACKGROUND

Improved survivorship among persons living with HIV translates into a higher risk of medical comorbidities.

OBJECTIVES

We assessed the association between the intersection of physical (HIV) and mental health (psychiatric) conditions and intermediate outcomes.

METHODS

This was a cross-sectional study of the Medical Expenditure Panel Survey (MEPS)- Household Component between 1996 and 2016. We created four groups for persons aged ≥18: (1) HIV + psychiatric comorbidity, (2) HIV, (3) psychiatric comorbidity, and (4) no-HIV/no-psychiatric comorbidity. We compared the burden of medical comorbidities (metabolic disorders, cardiovascular disease, cancers, infectious diseases, pain, and substance use) among groups using chisquare tests. We used logistic regression to determine the association between group status and medical comorbidity.

RESULTS

Of 218,133,630 (weighted) persons aged ≥18, 0.18% were HIV-positive. Forty-three percent of the HIV group and 19% of the no-HIV group had psychiatric comorbidities. Half of the HIV+ psychiatric disorder group had at least one medical comorbidity. Compared to the no- HIV/no-psychiatric comorbidity group, the HIV + psychiatric comorbidity group had the highest odds of medical comorbidity (OR= 3.69, 95% CI = 2.99, 4.52).

CONCLUSION

Persons presenting with HIV + psychiatric comorbidity had higher odds of medical comorbidities of pain, cancer, cardiovascular disease, substance use, metabolic disorders and infectious diseases, beyond that experienced by persons with HIV infection or psychiatric disorders, independently. Future research will focus on the mediating effects of social determinants and biological factors on outcomes such as the quality of life, cost and mortality. This will facilitate a shift away from the single-disease framework and compress morbidity of the aging cohort of HIV-infected persons.

摘要

背景

艾滋病毒感染者的生存状况得到改善,意味着他们面临更高的医疗合并症风险。

目的

我们评估了身体(艾滋病毒)和心理健康(精神健康)状况的交叉点与中间结果之间的关联。

方法

这是一项对 1996 年至 2016 年期间医疗支出面板调查(MEPS)家庭部分的横断面研究。我们为年龄≥18 岁的人群创建了四个组:(1)艾滋病毒阳性+精神健康合并症,(2)艾滋病毒,(3)精神健康合并症,以及(4)无艾滋病毒/无精神健康合并症。我们使用卡方检验比较了各组之间的医疗合并症(代谢紊乱、心血管疾病、癌症、传染病、疼痛和物质使用)负担。我们使用逻辑回归来确定组状态与医疗合并症之间的关联。

结果

在 218,133,630(加权)年龄≥18 岁的人群中,有 0.18%是艾滋病毒阳性。艾滋病毒组中有 43%和无艾滋病毒组中有 19%患有精神健康合并症。艾滋病毒+精神障碍组中有一半至少有一种医疗合并症。与无艾滋病毒/无精神健康合并症组相比,艾滋病毒+精神健康合并症组的医疗合并症的可能性最高(OR=3.69,95%CI=2.99,4.52)。

结论

患有艾滋病毒+精神健康合并症的人出现疼痛、癌症、心血管疾病、物质使用、代谢紊乱和传染病等医疗合并症的可能性高于仅感染艾滋病毒或患有精神疾病的人,这是独立的。未来的研究将侧重于社会决定因素和生物因素对生活质量、成本和死亡率等结果的中介作用。这将有助于从单一疾病框架转变,并压缩艾滋病毒感染人群老龄化队列的发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce1/9109776/8ae47da2cbce/nihms-1800916-f0001.jpg

相似文献

引用本文的文献

本文引用的文献

2
Pharmacotherapeutic options for kidney disease in HIV positive patients.HIV 阳性患者肾病的药物治疗选择。
Expert Opin Pharmacother. 2021 Jan;22(1):69-82. doi: 10.1080/14656566.2020.1817383. Epub 2020 Sep 21.
8
Metabolic Syndrome in HIV/HCV Co-infected Patients.HIV/HCV 合并感染患者的代谢综合征
Curr Treat Options Infect Dis. 2019 Dec;11(4):351-371. doi: 10.1007/s40506-019-00207-3. Epub 2019 Dec 2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验